159 related articles for article (PubMed ID: 25726032)
1. Association of visit-to-visit variability of hemoglobin A1c and medication adherence.
Ramachandran A; Winter M; Mann DM
J Manag Care Spec Pharm; 2015 Mar; 21(3):229-37. PubMed ID: 25726032
[TBL] [Abstract][Full Text] [Related]
2. A pilot study identifying statin nonadherence with visit-to-visit variability of low-density lipoprotein cholesterol.
Mann DM; Glazer NL; Winter M; Paasche-Orlow MK; Muntner P; Shimbo D; Adams WG; Kressin NR; Zhang Y; Choi H; Cabral H
Am J Cardiol; 2013 May; 111(10):1437-42. PubMed ID: 23433758
[TBL] [Abstract][Full Text] [Related]
3. Descriptive analysis of mail interventions with physicians and patients to improve adherence with antihypertensive and antidiabetic medications in a mixed-model managed care organization of commercial and Medicare members.
Jing S; Naliboff A; Kaufman MB; Choy M
J Manag Care Pharm; 2011 Jun; 17(5):355-66. PubMed ID: 21657805
[TBL] [Abstract][Full Text] [Related]
4. Age and sex-specific associations of visit-to-visit variability of glycated hemoglobin A1c with all-cause mortality in patients with diabetes.
Yeh ST; Ooi SW; Chang YH; Li CY; Chen HF
Medicine (Baltimore); 2022 Aug; 101(33):e29942. PubMed ID: 35984136
[TBL] [Abstract][Full Text] [Related]
5. Demographic and Clinical Profiles of Type 2 Diabetes Mellitus Patients Initiating Canagliflozin Versus DPP-4 Inhibitors in a Large U.S. Managed Care Population.
Grabner M; Peng X; Geremakis C; Bae J
J Manag Care Spec Pharm; 2015 Dec; 21(12):1204-12. PubMed ID: 26679969
[TBL] [Abstract][Full Text] [Related]
6. Risk of Nondherence to Diabetes Medications Among Medicare Advantage Enrollees: Development of a Validated Risk Prediction Tool.
Mhatre SK; Serna O; Sansgiry S; Fleming ML; Essien EJ; Sansgiry SS
J Manag Care Spec Pharm; 2016 Nov; 22(11):1293-1301. PubMed ID: 27783546
[TBL] [Abstract][Full Text] [Related]
7. Randomized trial of telephone outreach to improve medication adherence and metabolic control in adults with diabetes.
O'Connor PJ; Schmittdiel JA; Pathak RD; Harris RI; Newton KM; Ohnsorg KA; Heisler M; Sterrett AT; Xu S; Dyer WT; Raebel MA; Thomas A; Schroeder EB; Desai JR; Steiner JF
Diabetes Care; 2014 Dec; 37(12):3317-24. PubMed ID: 25315207
[TBL] [Abstract][Full Text] [Related]
8. The Association Between Antihypertensive Medication Nonadherence and Visit-to-Visit Variability of Blood Pressure: Findings From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
Kronish IM; Lynch AI; Oparil S; Whittle J; Davis BR; Simpson LM; Krousel-Wood M; Cushman WC; Chang TI; Muntner P
Hypertension; 2016 Jul; 68(1):39-45. PubMed ID: 27217410
[TBL] [Abstract][Full Text] [Related]
9. Relationship of oral antihyperglycemic (sulfonylurea or metformin) medication adherence and hemoglobin A1c goal attainment for HMO patients enrolled in a diabetes disease management program.
Lawrence DB; Ragucci KR; Long LB; Parris BS; Helfer LA
J Manag Care Pharm; 2006; 12(6):466-71. PubMed ID: 16925454
[TBL] [Abstract][Full Text] [Related]
10. Factors Associated with Diabetes-Related Clinical Inertia in a Managed Care Population and Its Effect on Hemoglobin A1c Goal Attainment: A Claims-Based Analysis.
Ruiz-Negrón N; Wander C; McAdam-Marx C; Pesa J; Bailey RA; Bellows BK
J Manag Care Spec Pharm; 2019 Mar; 25(3):304-313. PubMed ID: 30816810
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a program to improve diabetes care through intensified care management activities and diabetes medication copayment reduction.
Kogut SJ; Johnson S; Higgins T; Quilliam B
J Manag Care Pharm; 2012 May; 18(4):297-310. PubMed ID: 22548690
[TBL] [Abstract][Full Text] [Related]
12. A Retrospective Database Study Comparing Diabetes-Related Medication Adherence and Health Outcomes for Mail-Order Versus Community Pharmacy.
Schwab P; Racsa P; Rascati K; Mourer M; Meah Y; Worley K
J Manag Care Spec Pharm; 2019 Mar; 25(3):332-340. PubMed ID: 30816817
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal effects of medication nonadherence on glycemic control.
Egede LE; Gebregziabher M; Echols C; Lynch CP
Ann Pharmacother; 2014 May; 48(5):562-70. PubMed ID: 24586059
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the relationship between quality measure adherence definitions and economic outcomes in commercial health plans: a retrospective diabetes cohort study.
Chinthammit C; Axon DR; Mollon L; Taylor AM; Pickering M; Black H; Warholak T; Campbell PJ
J Manag Care Spec Pharm; 2021 Jan; 27(1):64-72. PubMed ID: 33377445
[No Abstract] [Full Text] [Related]
15. Predictive Validity of Self-Reported Measures of Adherence to Noninsulin Antidiabetes Medication against Control of Glycated Hemoglobin Levels.
Zongo A; Guénette L; Moisan J; Grégoire JP
Can J Diabetes; 2016 Feb; 40(1):58-65. PubMed ID: 26507401
[TBL] [Abstract][Full Text] [Related]
16. Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus.
Menzin J; Korn JR; Cohen J; Lobo F; Zhang B; Friedman M; Neumann PJ
J Manag Care Pharm; 2010 May; 16(4):264-75. PubMed ID: 20433217
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of an outpatient pharmacy clinical services program on adherence and clinical outcomes among patients with diabetes and/or coronary artery disease.
Spence MM; Makarem AF; Reyes SL; Rosa LL; Nguyen C; Oyekan EA; Kiyohara AT
J Manag Care Spec Pharm; 2014 Oct; 20(10):1036-45. PubMed ID: 25278326
[TBL] [Abstract][Full Text] [Related]
18. Predictors of Change in Adherence Status from 1 Year to the Next Among Patients with Type 2 Diabetes Mellitus on Oral Antidiabetes Drugs.
Saundankar V; Peng X; Fu H; Ascher-Svanum H; Rodriguez A; Ali A; Slabaugh L; Young P; Louder A
J Manag Care Spec Pharm; 2016 May; 22(5):467-82. PubMed ID: 27123910
[TBL] [Abstract][Full Text] [Related]
19. The Effect of Opioid Use and Mental Illness on Chronic Disease Medication Adherence in Superutilizers.
Surbhi S; Graetz I; Wan JY; Gatwood J; Bailey JE
J Manag Care Spec Pharm; 2018 Mar; 24(3):198-207. PubMed ID: 29485952
[TBL] [Abstract][Full Text] [Related]
20. Impact of health literacy level on aspects of medication nonadherence reported by underserved patients with type 2 diabetes.
Thurston MM; Bourg CA; Phillips BB; Huston SA
Diabetes Technol Ther; 2015 Mar; 17(3):187-93. PubMed ID: 25531555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
